Naomi Kresge

Stay informed with Naomi Kresge’s coverage and analysis for Fortune.

Page 2 of 4

  • Novo Nordisk CEO Lars Fruergaard Jorgensen InterviewRetail

    Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark

    By Sanne Wass, Naomi Kresge, and others
  • Novo Nordisk A/S Wegovy brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg via Getty ImagesHealth

    Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it

    By Naomi Kresge and Bloomberg
  • WHOHealth

    A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says

    By Naomi Kresge, Angela Feliciano, and others
  • Wegovy, an injectable prescription weight-loss medicine.Health

    A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’

    By Madison Muller, Naomi Kresge, and others
  • Drug trialHealth

    Roche is using AI to find the hardest-to-find lung cancer patients, with a potential blockbuster drug on the line

    By Naomi Kresge and Bloomberg
  • Katalin Kariko and Drew WeissmanHealth

    COVID vaccine scientists claim Nobel Prize in medicine

    By Naomi Kresge, Kati Pohjanpalo, and others
  • Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk, speaks during an interview in New York, US, on Wednesday, Aug. 10, 2022. Two more factories will begin producing Novo Nordisk A/S’s obesity medication Wegovy next year after manufacturing issues and high demand left the drug in short supply, Jorgensen said. Photographer: Christopher Goodney/Bloomberg via Getty ImagesHealth

    Taking new weight-loss drug Wegovy by pill is just as effective as a shot, study finds

    By Naomi Kresge and Bloomberg
  • Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk, speaks during a Bloomberg Television interview in New York, US, on Wednesday, Aug. 10, 2022. Two more factories will begin producing Novo Nordisk A/S’s obesity medication Wegovy next year after manufacturing issues and high demand left the drug in short supply, Jorgensen said. Photographer: Christopher Goodney/Bloomberg via Getty ImagesHealth

    Taking diet drug Wegovy for a year comes with a major added benefit, study finds

    By Naomi Kresge and Bloomberg
  • University hospital staff in ScotlandHealth

    Arthritis drug reduced risk of COVID deaths by 13%, U.K. study finds

    By Naomi Kresge and Bloomberg
  • BARI, ITALY – AUGUST 23: Box containing vials of the Modern covid-19 vaccine on August 23, 2021 in Bari, Italy. All Italian regions were invited to activate preferential lanes for people aged between 12 and 18, in order to encourage participation in the vaccination campaign and allow young people to receive the first dose of vaccine without booking. (Photo by Donato Fasano/Getty Images)Health

    Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies

    By Suzi Ring, Naomi Kresge, and others
  • 06 December 2021, Lower Saxony, Hanover: Rescue assistant Joachim Gerhardy of the Johanniter-Unfall-Hilfe prepares a vaccination of the Corona virus with the vaccine Comirnaty from Biontech in the former Rainforest Panorama at the Hannover Adventure Zoo. At the zoo, there is a new vaccination offer, which will then in the future be aimed primarily at children. Photo: Julian Stratenschulte/dpa (Photo by Julian Stratenschulte/picture alliance via Getty Images)Health

    Pfizer and BioNTech say booster dose is necessary to fight Omicron variant

    By Naomi Kresge and Bloomberg
  • The two-shot regimen for younger kids is one-third the dose that’s given to people ages 12 and older.Health

    Europe approves Pfizer-BioNTech COVID-19 vaccine for kids from 5 to 11

    By Naomi Kresge and Bloomberg
  • SAN RAFAEL, CALIFORNIA – OCTOBER 01: A vial of Pfizer COVID-19 booster vaccination sits on a table at a vaccination booster shot clinic on October 01, 2021 in San Rafael, California. Marin County opened its first COVID-19 booster shot clinic inside a former Victoria’s Secret store at Northgate Mall. The clinic is giving priority to residents over 75 years old but is open to all ages that are eligible to receive the Pfizer booster. (Photo by Justin Sullivan/Getty Images)Health

    Pfizer and BioNTech: Booster shot restores full COVID protection

    By Naomi Kresge and Bloomberg
  • DHAKA, BANGLADESH – SEPTEMBER 8, 2021: A nurse prepares the Moderna vaccine Booster Dose, during a Mass vaccination campaign at a vaccination center. On September 8, 2021 in Dhaka, Bangladesh. (Photo credit should read Sazzad Hossain / Eyepix Group/Barcroft Media via Getty Images)Health

    Most people don’t need COVID vaccine boosters yet, scientists say

    By Naomi Kresge and Bloomberg
  • SWITZERLAND – AUGUST 08: Switzerland, Basel, Headquarters of the Swiss chemical and pharmaceutical company F, Hoffmann-La Roche. (Photo by Ulrich Baumgarten via Getty Images)Health

    AC Immune shares surge on Alzheimer’s drug trial results

    By Naomi Kresge, James Paton, and others